DLK Gene (Dual Leucine Zipper Kinase) <div class="infobox infobox-gene">
<div class="infobox-row">
Overview ...
DLK Gene (Dual Leucine Zipper Kinase) <div class="infobox infobox-gene">
<div class="infobox-row">
Overview DLK (Dual Leucine Zipper Kinase, also known as MAP3K12) is a mitogen-activated protein kinase kinase kinase (MAP3K) that plays a critical role in [axonal injury](/mechanisms/axonal-degeneration) signaling. DLK is a key upstream activator of the [JNK pathway](/mechanisms/jnk-signaling-pathway) and has emerged as a promising therapeutic target for neurodegenerative diseases and nerve injury [@miller2009].
Function DLK functions as a master regulator of the stress-activated protein kinase (SAPK) signaling cascade:
Axonal Injury Response After axonal injury, DLK is rapidly activated and initiates a signaling cascade that:
Activates MLK4/MLK3 → MKK4/7 → JNK pathway
Promotes [Wallerian degeneration](/mechanisms/wallerian-degeneration) in distal axon segments
Regulates transcription of pro-apoptotic genes
Synaptic Function DLK plays a role in synaptic plasticity and function:
Regulates synaptic vesicle dynamics
Modulates [axon initial segment](/cell-types/neurons) integrity
Influences dendritic spine morphology
Apoptosis Under pathological conditions, DLK can promote neuronal death through:
JNK-mediated activation of pro-apoptotic proteins (BIM, BAD)
Caspase activation
Transcriptional regulation of cell death genes
The DLK-JNK Pathway in Neurodegeneration
Mermaid diagram (expand to render)
Expression DLK is predominantly expressed in:
Motor neurons — highest expression, relevant to ALSSensory neurons — dorsal root ganglia[Hippocampus](/brain-regions/hippocampus) — CA1 regionCortex — layer 5 pyramidal neuronsThe neuronal expression pattern makes DLK particularly relevant to diseases affecting specific neuron populations.
Disease Associations
Amyotrophic Lateral Sclerosis (ALS) DLK is strongly implicated in ALS pathogenesis:
Elevated activation in ALS motor neurons
Promotes excitotoxicity and oxidative stress
Genetic inhibition of DLK extends survival in animal models
Small molecule DLK inhibitors in clinical development
Alzheimer's Disease
DLK is elevated in AD brain tissue
JNK pathway activation correlates with tau pathology
May contribute to synaptic loss and neuronal death
Peripheral Neuropathy
DLK mediates chemotherapy-induced peripheral neuropathy
Involved in diabetic neuropathy
Inhibition protects against nerve damage
Traumatic Nerve Injury DLK is activated following nerve injury and drives Wallerian degeneration. Inhibition could potentially:
Preserve injured axons
Promote regeneration
Reduce neuropathic pain
Therapeutic Implications DLK represents a compelling therapeutic target:
Small molecule inhibitors : Several DLK inhibitors in development for ALS and peripheral neuropathyGene therapy : Antisense oligonucleotides targeting DLK mRNACombination therapy : DLK inhibition with other neuroprotective approaches
Challenges
DLK has both degenerative and regenerative roles — complete inhibition may impair nerve repair
CNS delivery of inhibitors remains challenging
Need to balance JNK pathway inhibition with normal cellular functions
Cross-references
[DLK Protein](/proteins/dlk-protein)
[JNK Signaling Pathway](/mechanisms/jnk-signaling-pathway)
[Axonal Degeneration](/mechanisms/axonal-degeneration)
[Wallerian Degeneration](/mechanisms/wallerian-degeneration)
[ALS Gene](/diseases/amyotrophic-lateral-sclerosis)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Motor Neurons](/cell-types/motor-neurons)
External Links
[NCBI Gene: DLK](https://www.ncbi.nlm.nih.gov/gene/7786)
[UniProt: DLK](https://www.uniprot.org/uniprot/Q16568)
[Ensembl: DLK](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116809)
References
[Miller BR, et al., DLK is a therapeutic target for axonal degeneration (2009)](https://pubmed.ncbi.nlm.nih.gov/19116269/)
[Holm KH, et al., Inhibition of DLK promotes neuronal survival after nerve injury (2019)](https://pubmed.ncbi.nlm.nih.gov/31178318/)
[Xin W, et al., DLK regulates Wallerian degeneration through AMPK and JNK signaling (2021)](https://pubmed.ncbi.nlm.nih.gov/34565758/)
[Leoni E, et al., DLK in neurodegenerative disease and regeneration (2022)](https://doi.org/10.1016/j.tins.2022.06.008)
Pathway Diagram The following diagram shows the key molecular relationships involving DLK — Dual Leucine Zipper Kinase discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description